Hemolytic Jaundice Induced by Pharmacological Dose Ascorbic Acid in Glucose-6-phosphate Dehydrogenase Deficiency: A Case Report

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2018 Dec 22

PMID 30572463

Citations 8

Authors

Shuxie Wu

Gao Wu

Hanbin Wu

Affiliations

Soon will be listed here.

Abstract

Rationale: Hemolysis induced by high dose ascorbic acid (AA) in patients with G6PD deficiency has been reported, but is rare. To our knowledge, this is the first reported case of a male with G6PD deficiency, coexpressed with cholecystolithiasis and cholecystitis, who developed extreme hemolysis and hyperbilirubinemia after receiving pharmacological doses ascorbic acid infusion.

Patient Concerns: A 27-year-old man history with glucose-6-phosphate dehydrogenase deficiency was admitted to our hospital because of cholecystolithiasis and cholecystitis. He appeared with scleral jaundice and very deep colored urine after receiving pharmacological doses ascorbic acid infusion.

Diagnoses: Clinical findings when combined with his medical history and various laboratory results confirmed the diagnosis as hemolysis and hyperbilirubinemia induced by ascorbic acid.

Interventions: The patient was treated with steroids, hepatoprotective drugs, and folic acid in addition avoidance of agents with known hemolysis risk (such as vitamin C).

Outcomes: As a result, the patient's symptoms from hemolytic jaundice improved, hemoglobin remained stable, and the patient was discharged 11 days later.

Lessons: Clinicians should bear in mind the possibility that vitamin C exposure may result in hemolysis in patients with G6PD deficiency, especially in those with known severe disease.

Citing Articles

Vitamin C-induced Hemolysis: Meta-summary and Review of Literature.

Juneja D, Jain R, Nasa P Indian J Crit Care Med. 2022; 26(2):224-227.

PMID: 35712748 PMC: 8857720. DOI: 10.5005/jp-journals-10071-24111.

Glucose-6-phosphate dehydrogenase deficiency contributes to metabolic abnormality and pulmonary hypertension.

Valuparampil Varghese M, James J, Rafikova O, Rafikov R Am J Physiol Lung Cell Mol Physiol. 2021; 320(4):L508-L521.

PMID: 33502933 PMC: 8238156. DOI: 10.1152/ajplung.00165.2020.

Commentary to "Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review".

Moran J, Herrera-Peco I Ann Intensive Care. 2020; 10(1):87.

PMID: 32632479 PMC: 7338324. DOI: 10.1186/s13613-020-00710-7.

The prevalence of glucose-6-phosphate dehydrogenase deficiency in the Cape Verdean population in the context of malaria elimination.

DePina A, Pires C, Andrade A, Dia A, Moreira A, Moreira Ferreira M PLoS One. 2020; 15(3):e0229574.

PMID: 32176714 PMC: 7075545. DOI: 10.1371/journal.pone.0229574.

Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review.

Honore P, Spapen H, Marik P, Boer W, Oudemans-van Straaten H Ann Intensive Care. 2020; 10(1):23.

PMID: 32052229 PMC: 7016079. DOI: 10.1186/s13613-020-0640-6.

References

May J, Qu Z, Morrow J . Mechanisms of ascorbic acid recycling in human erythrocytes. Biochim Biophys Acta. 2001; 1528(2-3):159-66. DOI: 10.1016/s0304-4165(01)00188-x. View

Nualart F, Rivas C, Montecinos V, Godoy A, Guaiquil V, Golde D . Recycling of vitamin C by a bystander effect. J Biol Chem. 2002; 278(12):10128-33. DOI: 10.1074/jbc.M210686200. View

May J, Qu Z, Cobb C . Human erythrocyte recycling of ascorbic acid: relative contributions from the ascorbate free radical and dehydroascorbic acid. J Biol Chem. 2004; 279(15):14975-82. DOI: 10.1074/jbc.M312548200. View

Huang H, Yan H, Han C, Yu F, Kao W, Chen W . Association of in vitro oxidative stress, serum ferritin concentration and C-reactive protein in febrile emergency room patients. Clin Invest Med. 2005; 28(2):48-54. View

Cappellini M, Fiorelli G . Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008; 371(9606):64-74. DOI: 10.1016/S0140-6736(08)60073-2. View

Montel-Hagen A, Kinet S, Manel N, Mongellaz C, Prohaska R, Battini J . Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C. Cell. 2008; 132(6):1039-48. DOI: 10.1016/j.cell.2008.01.042. View

Montel-Hagen A, Blanc L, Boyer-Clavel M, Jacquet C, Vidal M, Sitbon M . The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis. Blood. 2008; 112(12):4729-38. DOI: 10.1182/blood-2008-05-159269. View

Maha A . Effect of glucose-6-phosphate dehydrogenase deficiency on some biophysical properties of human erythrocytes. Hematology. 2009; 14(1):38-45. DOI: 10.1179/102453309X385061. View

Mehta J, Singhal S, Mehta B . Ascorbic-acid-induced haemolysis in G-6-PD deficiency. Lancet. 1990; 336(8720):944. DOI: 10.1016/0140-6736(90)92317-b. View

10.

Manganelli G, Fico A, Martini G, Filosa S . Discussion on pharmacogenetic interaction in G6PD deficiency and methods to identify potential hemolytic drugs. Cardiovasc Hematol Disord Drug Targets. 2010; 10(2):143-50. DOI: 10.2174/187152910791292547. View

11.

Padayatty S, Sun A, Chen Q, Espey M, Drisko J, Levine M . Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One. 2010; 5(7):e11414. PMC: 2898816. DOI: 10.1371/journal.pone.0011414. View

12.

Manganelli G, Masullo U, Passarelli S, Filosa S . Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits. Cardiovasc Hematol Disord Drug Targets. 2013; 13(1):73-82. DOI: 10.2174/1871529x11313010008. View

13.

Almeida S, Veiga J, Fernandes Arruda S, Neves C, Siqueira E . The association of markers of oxidative-inflammatory status with malnutrition in hemodialysis patients with serum ferritin lower than 500 ng/mL. J Bras Nefrol. 2013; 35(1):6-12. DOI: 10.5935/01012800.20130002. View

14.

Lang F, Lang E, Foller M . Physiology and pathophysiology of eryptosis. Transfus Med Hemother. 2013; 39(5):308-14. PMC: 3678267. DOI: 10.1159/000342534. View

15.

Arese P, Gallo V, Pantaleo A, Turrini F . Life and Death of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Erythrocytes - Role of Redox Stress and Band 3 Modifications. Transfus Med Hemother. 2013; 39(5):328-34. PMC: 3678266. DOI: 10.1159/000343123. View

16.

Theil E . Ferritin: the protein nanocage and iron biomineral in health and in disease. Inorg Chem. 2013; 52(21):12223-33. PMC: 3882016. DOI: 10.1021/ic400484n. View

17.

Ali E, Ahmed E . The role of erythrocyte enzyme glucose-6-phosphate dehydrogenase (G6PD) deficiency in the pathogenesis of anemia in patients on hemodialysis. Saudi J Kidney Dis Transpl. 2013; 24(6):1153-6. DOI: 10.4103/1319-2442.121271. View

18.

van Zwieten R, Verhoeven A, Roos D . Inborn defects in the antioxidant systems of human red blood cells. Free Radic Biol Med. 2013; 67:377-86. DOI: 10.1016/j.freeradbiomed.2013.11.022. View

19.

Tian W, Wang Y, Xu Y, Guo X, Wang B, Sun L . The hypoxia-inducible factor renders cancer cells more sensitive to vitamin C-induced toxicity. J Biol Chem. 2013; 289(6):3339-51. PMC: 3916538. DOI: 10.1074/jbc.M113.538157. View

20.

Cisternas P, Silva-Alvarez C, Martinez F, Fernandez E, Ferrada L, Oyarce K . The oxidized form of vitamin C, dehydroascorbic acid, regulates neuronal energy metabolism. J Neurochem. 2014; 129(4):663-71. DOI: 10.1111/jnc.12663. View